The scaling back of nonessential visits to prevent the spread of COVID-19 led to a precipitous decline in cancer screening, which may lead to an increase in later-stage cancer diagnoses.

Individuals with certain underlying medical conditions, including cancer, are at an increased risk for severe COVID-19 illness.

The COVID-19 pandemic led to the expanded use of telemedicine, which has expanded the delivery of oncology services to patients with cancer.